GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CBAN · Sep 30, 2025

COLONY BANKCORP INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000711669-25-000158Bank
Sequential deposit growth50thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

1.10% · CORE · VALID

Net-income growth25thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

3.38% · CORE · VALID

Interest-income growth25thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

6.61% · CORE · VALID

Cash and equivalents90thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$200.0M · CORE · VALID

Sequential loan growth60thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

2.26% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History60 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-2.53%
Current
1.10%
Delta
3.63%
Earnings Growth Decreased
Previous
45.74%
Current
3.38%
Delta
-42.37%
Interest Income Growth Decreased
Previous
10.50%
Current
6.61%
Delta
-3.88%
Liquidity Increased
Previous
$112.1M
Current
$200.0M
Delta
$87.8M
Loan Growth Decreased
Previous
3.85%
Current
2.26%
Delta
-1.59%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.